Objective: The purpose of this study was to compare the energy cost of standardized physical activity (ECA) between patients with cystic ®brosis (CF) and healthy control subjects. Design: Cross-sectional study using patients with CF and volunteers from the community. Setting: University laboratory. Subjects: Fifteen patients (age 24.6 AE 4.6 y) recruited with consent from their treating physician and 16 healthy control subjects (age 25.3 AE 3.2) recruited via local advertisement. Interventions: Patients and controls walked on a computerised treadmill at 1.5 kmah for 60 min followed by a 60 min recovery period and, on a second occasion, cycled at 0.5 kp (kilopond), 30 rpm followed by a 60 min recovery. The ECA was measured via indirect calorimetry. Resting energy expenditure (REE), nutritional status, pulmonary function and genotype were determined. Results: The REE in patients was signi®cantly greater than the REE measured in controls (P 0.03) and was not related to the severity of lung disease or genotype. There was a signi®cant difference between groups when comparing the ECA for walking kg p FFM (P 0.001) and cycling kg p FFM (P 0.04). The ECA for each activity was adjusted (ECA adj ) for the contribution of REE (ECA kJ kg p FFM 120 min 71 7 REE kJ kg p FFM 120 min 71 ). ECA adj revealed a signi®cant difference between groups for the walking protocol (P 0.001) but no difference for the cycling protocol (P 0.45). This ®nding may be related to the fact that the work rate during walking was more highly regulated than during cycling. Conclusions: ECA in CF is increased and is likely to be explained by an additional energy-requiring component related to the exercise itself and not an increased REE.
Introduction
Cystic ®brosis (CF) is a clinical disorder characterised by abnormal exocrine gland function. The main effects are on the respiratory system, the digestive system and the sweat glands. There are many complications associated with the disease process, including chronic lung disease, malabsorption and malnutrition, which cause an increase in energy requirements (Vaisman et al, 1987a,b; Buchdahl et al, 1988; Grunow et al, 1993; Horswill et al, 1994; Bell et al, 1995) . Hence, measurement of resting energy expenditure (REE) and total energy expenditure (TEE) is crucial to aid in optimal therapeutic regimes.
REE in patients with CF is often reported to be 10 ± 20% greater than in healthy subjects (Vaisman et al, 1987a,b; Buchdahl et al, 1988; O'Rawe et al, 1992; Grunow et al, 1993; Horswill et al, 1994; Bell et al, 1995 Bell et al, , 1999 Stallings et al, 1998) . Although the speci®c reasons for this increase are unclear, the rise has been attributed to a number of possible mechanisms. These include declining pulmonary mechanics (Vaisman et al, 1987a; Buchdahl et al, 1988; Fried et al, 1991; Amin & Dozor, 1994) , malnutrition (Vaisman et al, 1987a,b; Naon et al, 1993; Zemel et al, 1996) , in¯ammation of the infectious agents within the lungs (Buchdahl et al, 1988; Naon et al, 1993; Steinkamp et al, 1993; Bell et al, 2000) , genetics (O'Rawe et al, 1990 (O'Rawe et al, , 1992 Thomson et al, 1996; Zemel et al, 1996) and cellular iron transport defects (Feigal & Shapiro, 1979; Stutts et al, 1986 ).
An increase in REE does not necessarily imply an increase in TEE, and hence energy requirement. This is because the latter also includes physiological parameters such as the energy cost of physical activity, the metabolic response to food and, in the case of children, the energy cost of growth (Spicher et al, 1991) . In adults, the REE accounts for 60 ± 75% of TEE, physical activity for approximately 20 ± 30%, thermogenesis for 5 ± 10% and growth less than 1% (Elia, 1992) . The major cause, therefore, of inter-individual variability in TEE is the energy cost of physical activity (Goran et al, 1993) . Using the heart-rate method, researchers (Spicher et al, 1991) have found that in free-living conditions, TEE in patients with CF is not higher than in control subjects. Alternatively, using the doubly labelled water method, others (Tomezsko et al, 1994) have found TEE in CF is 15 ± 18% greater than in healthy age-matched controls. Only one study to date has examined the amount of energy expended by patients with CF during physical activity per se (Grunow et al, 1993) . Using open-circuit indirect calorimetry, these workers demonstrated that, compared to control subjects, energy expenditure in children with CF at rest, during sitting and standing, and during two levels of exercise was signi®-cantly increased. It was also reported that the incremental increases from one level of activity to another did not differ, thus suggesting that the energy requirements during exercise were greater due to the in¯uence of REE not an additional energy-requiring component related to the physical activity itself. Clearly, expanded knowledge of the energy cost of physical activities in CF would be useful to further explore the relationship between activity and TEE, and also to provide detailed information relating speci®cally to energy balance and energy requirement.
This study was undertaken to provide a better understanding of the energy requirements during exercise in patients with cystic ®brosis. The purpose of this study was to compare the energy cost of activity (ECA) during standardised sessions and the energy expended in a subsequent recovery period between patients with CF and healthy control subjects.
Methods

Subjects
Fifteen young adults with CF (seven male; eight female) attending the local adult CF clinic were recruited via physician referral to participate in this study. The criteria for inclusion were the following: diagnosis of symptomatic CF; absence of a prescribed exercise programme in the daily routine; !18-y-old; forced expiratory volume in 1 s (FEV 1 ) !1.5 l; clinically stable (de®ned as no change in symptoms or treatment in the preceding 4 weeks and an FEV 1 within 10% of the best recorded in the previous 12 months); and no medical contraindications for exercise testing.
A group of 16 healthy control subjects with no history of cardio-respiratory disease were recruited from the community via local advertisement. In an effort to maintain homogeneity controls were selected according to their age, body composition and gender so that they were similar to the CF group.
The study was carried out in the Human Movement Studies Department at Queensland University of Technology (QUT). The experimental procedures were explained to all patients and controls and written informed consent was obtained. The study was approved by the QUT Human Research Ethics Committee and the Prince Charles Hospital Ethics Committee.
Experimental design
Patients with CF were required to report to the laboratory on two separate occasions for testing. Evaluation of resting energy expenditure (REE), nutritional status and pulmonary function were made on the same morning. Following these measurements, subjects reported to the exercise laboratory to perform a 60 min walk on a computerised treadmill at 1.5 kmah. This was followed by a 60 min recovery period where subjects rested quietly in the supine position. The second visit involved cycling on a stationary ergometer for 60 min at 0.5 kp, 30 rpm (15 W) followed by a 60 min recovery period. These activity sessions were chosen for this protocol as it was thought that they were within the range of capabilities for patients with CF and they provide weight-bearing and non-weight-bearing comparisons. In addition, the intensities at which the exercise was performed were representative of the energy demands placed on patients during activities of daily living. For both exercise protocols ECA was measured during the exercise and recovery periods via indirect calorimetry.
Nutritional assessment
Weight and height were measured using standard techniques. Lean body mass (LBM) was determined by deuterium ( 2 H 2 O) dilution . This involved the collection of a baseline urine sample followed by the ingestion of deuterium oxide (10%; 0.5 ml kg body weight 71 ). A second urine sample was then collected after 5 h. Fat-free mass (FFM) was determined using total body water (TBW) values from 2 H 2 O dilution, assuming a 73% hydration factor of FFM in adults (Forbes, 1962) .
Pulmonary function
Pulmonary function was assessed with a vitalograph spirometer. Measurements included forced vital capacity (FVC), forced expiratory volume in one second (FEV 1 ), peak expiratory¯ow (PEF) and forced expiratory¯ow between 25 and 75% (FEF 25 ± 75% ). Results were expressed as absolute values and as percentage of reference values predicted for gender, age and height (Morris, et al, 1984) .
Energy cost of physical activity in CF ML Richards et al
Resting energy expenditure REE was determined via open circuit indirect calorimetry using the ventilated hood method. Patients were advised to maintain habitual eating plans and activity levels for 5 days leading up to the measurement and were required to fast (except for water) for a period of 12 h overnight prior to testing. All patients who were prescribed b-agonist or theophylline therapy were required to withhold their medications for at least 12 h. Patients were scheduled to arrive at the QUT Human Movement Studies Clinic between 8.00 am and 9.00 am on their testing days. On arrival for their REE assessment patients were requested to lie quietly for 15 min before testing began. REE was then measured for 45 min in a supine position using a ventilated hood attached to a computerised metabolic cart (Deltatrac). Oxygen consumption and CO 2 production were recorded minute by minute for the last 25 ± 30 min of the test for each patient. The equation of Weir (1949) was used to calculate the REE.
Energy cost of activity assessment
Prior to the ®rst activity session, patients were accustomed to the apparatus for collecting expired breath. Oxygen uptake and carbon dioxide production were measured for the ®rst and last 20 min of each exercise session and for three 10 min intervals during the recovery periods. Expired gas was collected using a mouthpiece, two-way breathing valve (Hans Rudolph) and Douglas bags. The fractional concentrations of CO 2 and O 2 were measured with a Morgan Analyser (P.K. Morgan Ltd, Rainham, Kent, England) and the total volume of expired air was determined by emptying the bag into a gas meter.
Statistical analysis
Results were expressed as mean AE standard deviation (s.d.). Log ± log regression analysis was carried out to determine the most appropriate way to express the energy expenditure data relative to FFM. Independent t-tests were used to measure distribution differences between patients and controls. Correlation coef®cients were determined to assess the relationship between variables. P`0.05 was considered statistically signi®cant.
Results
The physical characteristics of patients and control subjects are presented in Table 1 . Both groups were well matched for age, weight, height and body composition with no signi®cant differences reported. The pulmonary function tests showed signi®cant differences between groups for FEV 1 , FVC, PEF and FEF 25-75% (P`0.0001).
Of the 15 patients tested, nine were homozygous for the DF508 mutation and 13 were pancreatic insuf®cient. All patients had chronic Pseudomonas aeruginosa infection.
Log ± log regression analysis revealed that, to remove the bias between groups, data needed to be expressed relative to the square root of fat-free mass. 
{
Signi®cantly different from walking (P`0.05). Energy cost of physical activity in CF ML Richards et al REE was higher in patients with CF than in controls (P`0.0001). This remained so when expressed in relation to body weight (P`0.001), FFM (P`0.05) or p FFM (P`0.001) (see Table 2 ). We did not ®nd a correlation between REE and pulmonary function (FEV 1 , FVC, PEF or FEF 25 ± 75% ) or genotype. The mean ECA for walking was signi®cantly different between groups when expressed per kilogram of Energy cost of physical activity in CF ML Richards et al FFM (P`0.05), but did not differ for cycling (see Table 2 ). When expressed relative to p FFM both walking and cycling ECA was signi®cantly different between groups (P`0.05). The recovery energy expenditure values were signi®cantly higher in patients after walking (P`0.05) but after cycling the increase in energy expenditure during recovery in the CF group did not reach signi®cance. Patients used signi®cantly ). This allowed us to examine the differences in ECA adj and recovery EE adj between groups, independent of the differences observed in REE. ECA adj revealed a signi®cant difference between groups for walking (P`0.05; Figure 1 ) but no difference for cycling (Figure 2 ). Recovery EE adj showed no differences between groups for either protocol (Figures 3 and 4) .
We found no relationships between walking ECA adj and pulmonary function or genotype in the CF group that could explain the increase observed compared to controls. Further, there were no observed differences between patients who were homozygous for the DF508 mutation and those who were heterozygous for any of the variables measured.
Discussion
The present study adds to current knowledge of energy expenditure in patients with CF. It has been con®rmed that REE is elevated in patients which is consistent with previous research (Vaisman et al, 1987a,b; Buchdahl et al, 1988; O'Rawe et al, 1992; Grunow et al, 1993; Horswill et al, 1994; Bell et al, 1995 Bell et al, , 1999 Stallings et al, 1998) . There were also signi®cant increases in the ECA in patients with CF during walking, even when the contribution of REE was accounted for. A similar increase in ECA in patients during cycling was not found.
The current results demonstrated an increase in mean REE in patients that was 14% greater than the mean REE measured in controls. The differences were signi®cant when expressed in absolute terms and also in terms of body weight, FFM and p FFM. There is some evidence that this energy metabolism disorder is genetically conditioned (O'Rawe et al, 1992; Thomson et al, 1996) , however the current study did not support this hypothesis. There was no relationship between REE and genotype, which is consistent with others (Fried et al, 1991; Tomezsko et al, 1994) . Researchers have also suggested that the increase in REE is related to pulmonary function (Vaisman et al, 1987a,b; Buchdahl et al, 1988; Fried et al, 1991; Amin & Dozor, 1994) , however this study did not ®nd any relationship between REE and FEV 1 or FVC. This may be due to the small sample size or the small range in pulmonary function scores observed in this study. In¯ammatory indices, although not measured in this study, have also been related to an elevated REE (Steinkamp et al, 1993) . This suggests that the in¯ammation of chronic lung disease might play an important role in determining the metabolic requirement in CF. It is clear, therefore, that the REE in patients with CF is elevated relative to predicted values or control subjects, but its association with clinical status remains controversial. The current results demonstrated that during walking, which was of very low intensity, the ECA adj in patients was signi®cantly greater than in healthy controls matched for age, weight, gender and FFM. This was not so for cycling. The patients in this study had mild lung disease compared to the healthy controls who had normal respiratory function. Therefore we could speculate that the increase in ECA adj during walking in patients was due to subtle differences observed in pulmonary mechanics between the two groups. However, there was no relationship between ECA adj and a marker of the severity of lung disease, spirometric measures. This may be due to the fact that spirometry is a crude measure of pulmonary mechanics. Perhaps future studies should employ more sophisticated measures to determine the status of lung disease in patients.
The walking protocol was electronically controlled by computerised treadmill operation, and therefore differences between the intensity level for patients and controls could not explain the observed results. During cycling, however, a computer did not regulate the intensity but rather patients were required to cycle at a constant rate of 30 rpm, hence differences in the actual workload may have occurred between groups. Cycle ergometers were preset with the prescribed resistance of 30 rpm and consistent encouragement was provided so that this intensity was maintained throughout the exercise period. Although we continually supervised the exercise and controlled for variations in rpm by regularly checking the intensity on the cycle ergometer, we did not have the personnel to delegate a single supervisor the task of recording changes in rpm. It is therefore possible that controls worked harder during this protocol which would explain the lack of difference between groups for the cycling protocol. Further studies should employ protocols that are controlled electronically to avoid possible differences in the work output between groups.
Results in this study were compared after the energy expenditure data were expressed relative to p FFM. This phenomenon is well recorded in the literature (Davies, 1992; Wells & Davies, 1995) . Log ± log regression analysis enabled the measurement of energy expenditure to be adjusted appropriately for FFM. Even when ECA was appropriately expressed relative to p FFM our ®ndings remained the same with a signi®cant difference between patients and controls for walking ECA adj but no difference in the cycling ECA adj value. Previous studies have speculated about the ECA in patients with CF by using the TEEaREE ratio as an indicator of physical activity levels. Spicher et al, (1991) found no differences in the TEEaREE ratios between patients and controls. Tomezsko et al, (1994) also found no differences between pre-pubertal children with mild lung disease and CF and healthy controls, however they did ®nd a signi®cant difference between the DF508 homozygous subgroup and the mixed heterozygous group of patients. The current results did not demonstrate any differences in ECA between patients in different genotype subgroups.
The ECA of a group of female adolescents with CF was investigated by Grunow et al (1993) . The patients in their study had a mean FEV 1 of 89.8% of the predicted value, indicating mild lung disease, and were all well nourished. Results demonstrated that the energy expended during resting, sitting and standing was signi®cantly greater in patients than in controls. During exercise at 30 W and then 50 W, however, no differences between groups were observed. When the ECA was adjusted for the contribution of REE, no differences were observed between groups for any of the activities described. Our data for the walking protocol does not support these ®ndings as we found the ECA adj was signi®cantly increased in patients. The main difference between the two studies was the expression of ECA. Grunow et al (1993) did not make any adjustments for body weight or FFM whereas the present study expressed the ECA in relation to FFM as measured by deuterium dilution. Also, the differences could be attributed to the fact that our measurement period was steady state whereby we measured ECA for a 60 min period during the activity session. Grunow et al (1993) measured the EE for each of their activities for only 15 min and used data for the last 8 ± 12 min of each phase for analysis. It may be possible that their patients were still in a state of metabolic shift resulting from a higher oxygen de®cit. Studies in healthy individuals show that in the transition from rest to light exercise, oxygen consumption (VO 2 ) in a trained athlete increases rapidly and reaches a steady state within four minutes (Coggan & Coyle, 1991) . Patients with CF, however, may experience signi®cant delays due to respiratory complications (Hirsch et al, 1989 ) and a limited aerobic bioenergetic capacity. This would be similar to the response of untrained athletes (Hickson et al, 1978; Powers & Beadle, 1985) . Further knowledge in this area is needed.
We conclude that the ECA in clinically stable, well nourished young adults with CF and mild lung disease is elevated even when the contribution of REE is removed. A high REE combined with an increased ECA puts patients at risk of nutritional compromise. The occurrence of malnutrition has been associated with poor survival in patients with CF (Corey et al, 1988) and therefore the nutritional prescription should account for increased energy needs, especially when additional physical activities are incorporated into the lifestyle of a patient. In addition, efforts should be made to reduce the possibility of an inactive lifestyle, and physical activity promoted in conjunction with caloric supplementation, to ensure the maintenance of energy balance.
